Close Menu

NEW YORK (GenomeWeb) — Cancer Genetics (CGI) and NovellusDx announced today that they have agreed to merge.

The transaction will combine CGI's portfolio of cancer tests and laboratory service offerings with NovellusDx's next-generation sequencing and machine-learning technologies for cancer treatment response prediction.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.